Skip to main content
    D

    Dr. Reddy’s Laboratories Ltd ADR (RDY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $14.80
    +0.10 (+0.68%)

    Market Cap: $12.29B

    Last updated: Nov 17, 2026 at 4:37 PM ET

    Dr. Reddy’s Laboratories Ltd ADR (RDY) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Dr. Reddy’s Laboratories Ltd ADR (RDY) has a latest price of $14.80 on Nov 17, 2026, 4.5% below its 52-week high of $15.49. Its price rose 6.9% over the past 12 months. The month-end price rose 43.7% over the 10 years through Oct 2026, a compound annual rate of 3.7%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $16.69 in Aug 2024 and its lowest $5.70 in May 2018, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RDY with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RDY.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 22.2%, and over 6 months it rose 10.8%. The month-end price rose 8.8% over the 3 years through Oct 2026, a compound annual rate of 2.8%.

    PeriodChange
    1 month+13.1%
    3 months+22.2%
    6 months+10.8%
    12 months+6.9%
    12 months, with dividends+8.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+8.8%+2.8%
    5 years+15.3%+2.9%
    10 years+43.7%+3.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 75.7%, and its weakest was 2022, when it fell 20.9%.

    YearCloseChange
    2026 through Oct 2026$14.17+0.9%
    2025$14.04-11.1%
    2024$15.79+13.5%
    2023$13.92+34.5%
    2022$10.35-20.9%
    2021$13.08-8.2%
    2020$14.26+75.7%
    2019$8.12+7.6%
    2018$7.54+0.4%
    2017$7.51-17.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 12.5% above its 50-day average of $13.15 and 11.8% above its 200-day average of $13.24.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$14.80
    52-week high$15.49-4.5%
    52-week low$11.28+31.2%
    50-day average$13.15+12.5%
    200-day average$13.24+11.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 32.0%.

    MeasureValue
    1-year beta0.35
    Largest fall, 1 year-26.0%
    Largest fall, 3 years-32.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RDY

    What is RDY's 1-year price change?

    Dr. Reddy’s Laboratories Ltd ADR's price rose 6.9% over the past 12 months. With dividends included, the 12-month total return was 8.0%.

    What is RDY's 5-year price change?

    Dr. Reddy’s Laboratories Ltd ADR's month-end price rose 15.3% over the 5 years through Oct 2026, a compound annual rate of 2.9%. These figures leave out dividends.

    What is RDY's 52-week high and low?

    Dr. Reddy’s Laboratories Ltd ADR's 52-week high is $15.49 and its 52-week low is $11.28. Its latest price of $14.80 on Nov 17, 2026 is 4.5% below the high.

    What is RDY's beta?

    Dr. Reddy’s Laboratories Ltd ADR's 1-year beta against the S&P 500 is 0.35, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 26.0%.

    Is the RDY chart free?

    Yes. Advanced Charting for RDY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.